Skip to main content
Clinical Trials/NL-OMON41589
NL-OMON41589CompletedNot Applicable

The efficacy of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a pilot study. - walk-bike IPF

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites11 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
11

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • -IPF patients
  • -Diagnosis of IPF, including probable and possible diagnosis according to ATS/ERS criteria
  • -Written informed consent
  • -TLCOc >= 25% (pred) and FVC >= 50% (pred)
  • -6MWD >= 150 m
  • -Being clinically stable
  • -Absolute decline in TLCOc and FVC should be less than 10% in the past 6 months.

Exclusion Criteria

  • -Participation in a formal rehabilitation program within 4 months of start of study
  • -Musculoskeletal disorders
  • -Severe cardiac diseases (ejection fraction < 30%, daily angina, or otherwise specified by treating cardiologist)
  • -Unable to understand informed consent
  • -Other conditions that hamper the use of a walk-bike

Investigators

Similar Trials

The efficacy of the walk-bike on quality... | Clinical Trial